7 ms·
Polyethylene glycol is an adjuvant, as are many of the lipids chosen. It's looking like PEG is maybe a bit too effective at getting the immune system's attenti
by mlyle 6y ago
Polyethylene glycol is an adjuvant, as are many of the lipids chosen. It's looking like PEG is maybe a bit too effective at getting the immune system's attention, and that's why we're getting so much anaphylaxis.
We know that both the Moderna and Pfizer vaccines look about 80% effective from 10 days after dose 1 up to dose 2. We really should be doing a trial on delaying dose 2 a bit: it might very well make the dose 2 side effects smaller, increase efficacy, and stretch vaccine supplies.
- maxerickson 6y ago11 or 12 per million might better be described as "higher rates of anaphylaxis than other widely used vaccines". In absolute terms it's not a lot. Even for younger adults, chances of dying if infected with Covid are much higher than that.
- mlyle 6y agoOh, of course. The vaccines have a higher side effect rate than we're used to, but they're orders of magnitude safer than the risk we have from being exposed to COVID, infected, and then having a bad outcome. Some of this relates to the rush to market and the desire for very high efficacy even if we were somewhat surprised/incorrect on required neutralization titers. When COVID-19 is rarer, we likely will need safer vaccines against it, though. This may just be a question of turning down dosage a bit.
- EpiMath 6y agoAgreed, and current estimates are more on the order of 4 to 5 per million. A high proportion of these cases are among people with a history of anaphylactic reactions to drugs, needle sticks or food/tree nuts ( many were already carrying their own epi pens! ) so it includes people who probably would skip an annual flu vaccine but of course do not want to skip this one. I'm not trying to suggest that the rate isn't higher than other vaccines, but it may not be as much higher as it first appeared. ( Also, to be fair, now that there is so much vigilance, it's possible that a number of pre-anaphylaxis are being caught early and treated with epi or benadryl before they could become full-blown anaphylaxis. So, this could make the rate appear lower. These things always need to be considered thoughtfully! ) As others have pointed out, the risk/benefit calculation here is extreme: a few bad reactions per million vs. a disease that has already killed more than 1000 people per million population in the US.
- nwellnhof 6y ago> Even for younger adults, chances of dying if infected with Covid are much higher than that. For a healthy young adult, chances of dying from Covid are in the same ballpark.
- maxerickson 6y agoThe above is ~1/100,000. IFR (which is compatible with what I said) for 19 and younger is 3/100,000, but that includes younger people that are even less impacted. So it is sort of the same ballpark for the very youngest adults, but a factor of 3 isn't nothing. It's higher for people in their 20s already. We can be talking about different things though, as it isn't 100% likely a given person will be infected.
- mlyle 6y agoIt's likely pretty close to the same. 2-4x the rate if infected; about a 1/2-1/4th chance of becoming infected eventually if no vaccine.
- monopoledance 6y agoThing is, the "not healthy" group is bigger than most people think. Anaphylaxis is a very controllable situation, whereas severe COVID is not. Non of the reacting subjects hasn't had a history of anaphylaxis AFAIK. Nothing in the mRNA vaccines was chosen to enhance immune response, nothing is an adjuvant as with other vaccines. On the contrary, the polymers and co are there to protect the mRNA from immune system clearance (and are used in other non-vaccine medications too). It's worth noting, an allergic reaction is mediated by a completely different branch of the immune system. Non of the "adjuvants" aren't to be found in common household items, food and cosmetics, which is probably why the allergic people reacted in the first place. Very few, very allergic people, seem to react to these. If so, you treat them with an antihistamine and similar.
- mlyle 6y ago> Nothing in the mRNA vaccines was chosen to enhance immune response, nothing is an adjuvant as with other vaccines. This isn't -exactly- true. There's no traditional adjuvant added, but... the fact that the formulation caused adjuvant-like effects was seen as a feature, not a bug. Added care to minimize immune response has been used in the development of mRNA drug platforms > Non of the "adjuvants" aren't to be found in common household items, food and cosmetics You can find PEG in lots of things, but PEGylated large molecules aren't exactly common items around the home.
- randymercury 6y agoI believe that is what the British are doing.
- mlyle 6y agoNah, the British are just delaying the doses, without any kind of trial in play (other than population-level observation).
- Closi 6y agoThere has been a study now, it's just not gone through peer review yet. https://www.ft.com/content/de00fe75-9ba1-4be7-8cf1-6e9fa55f09ce https://www.ft.com/content/de00fe75-9ba1-4be7-8cf1-6e9fa55f0... Additionally the advice to delay the second dose is now also part of the WHO recommendations.
- mlyle 6y agoNote that this is the AZ vaccine. They're also stretching second doses of the Moderna vaccine, which is what we were talking about trialing here.